A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...

Chinese scientists have found that a common treatment wakes up dormant cancer cells, causing the deadly disease to spread from the original sites to other organs., Health, Times Now ...

New research shows how cells carrying damaged DNA can sidestep cell cycle checkpoints that should prevent them from dividing ...

Writing poems following my lymphoma diagnosis gave me hope and purpose as I endured chemo, helping me heal and share my ...

Researchers find that disrupted circadian rhythms may impair gut regeneration and microbiome balance, heightening colon ...

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

Mayo Clinic physician and researcher Dr. Abba Zubair's work combines two passions—medicine and space—for the benefit of astronauts and people on Earth. His research in space is yielding discoveries in ...

Introduction Many chemotherapy agents used to treat advanced cancer are inherently mucotoxic, causing breakdown of the gastrointestinal mucosa (gastrointestinal mucositis (GI-M)) and lead to a ...

Treatment with tarlatamab led to longer overall survival than chemotherapy among patients with small-cell lung cancer whose disease had progressed during or after platinum-based chemotherapy.

Abstract 8548 Background: In the treatment of advanced non-small cell lung cancer (NSCLC), the combination of anti-PD1 and chemotherapy has demonstrated an advantage over chemotherapy alone.